mRNA-based vaccines

#eBook #Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines #RNA #tRNA

eBook: mRNA innovation in drug discovery

The success of mRNA-based vaccines for Covid-19 pushed messenger RNA into the spotlight. However, its uses in drug discovery and development aren’t just confined to vaccines – applications include personalised medicine and therapeutics, for example. This eBook, sponsored by Promega, examines the latest innovations that are… Read More

#News

#mRNA #mRNA-based vaccines #Promega #Therapeutics

Bridge innovation to implementation with high-quality RNA therapeutic raw materials 

This article is sponsored by Promega. In today’s fast-paced RNA therapeutic development landscape, experience matters. With over 40 years of experience in RNA synthesis by in vitro transcription (IVT), Promega smooths the transition from research to production by reducing risk and saving time, without compromising the quality of RNA synthesis… Read More

#News

#Cancer therapeutics #Cancer vaccine #Immunotherapy #mRNA-based vaccines #Oncology

A deep dive into cancer vaccines

Megan Thomas explores the innovation and opportunity for cancer vaccines with Dr Alexander Zehnder, CEO of CureVac, and Dr Chris Haqq, Chief Medical Officer of Elicio Therapeutics. It could be argued that Covid-19 gave us a boost to start making headway in cancer vaccines. Between the acceleration of mRNA vaccine… Read More

#Cancer Research #Exclusive Content

Vaccine production
#Cancer vaccine #mRNA #mRNA-based vaccines #Oncology #Personalised medicine #University of Queensland

Personalised cancer vaccines to be produced at Queensland lab

A new facility at The University of Queensland, Australia, will provide researchers with cancer vaccines tailored to individual patients. The lab at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) will bring together the equipment and expertise to enable the design, manufacture and delivery of new… Read More

#News

#FDA #Immunology / Virology & Vaccines #Moderna #mRNA #mRNA-based vaccines #Respiratory syncytial virus

US approves first mRNA vaccine since Covid-19

The US Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. The approval was granted under a breakthrough therapy designation and marks the second approved mRNA… Read More

#News #Regulatory

#Covid-19 vaccine #mRNA #mRNA-based vaccines #Oncology #RNA

The future outlook for mRNA therapies

Reece Armstrong explores the potential and future opportunities for mRNA-based therapies. Messenger RNA (mRNA) has come into focus within the drug discovery and development as an exciting tool to deliver genetic information. Whilst research into mRNA has been ongoing for decade, interest has sparked in recent years and research has… Read More

#Exclusive Content

Vaccine vial and syringe
#Cancer vaccine #Imperial College London #Moderna #mRNA-based vaccines #Oncology #Phase I trial

First UK patients receive experimental mRNA therapy for cancer

The first UK patients have received an mRNA cancer therapy – mRNA-4359 – as part of a Phase I/II clinical trial investigating its potential for treating melanoma, lung cancer and other solid tumour cancers. The Mobilize trial is run in partnership between Imperial College London and… Read More

#Cancer Research #News #Trending News

Katalin Karikó and Drew Weissman
#Covid-19 vaccine #Karolinska Institutet #mRNA #mRNA-based vaccines #Nobel Prize

mRNA pioneers Katalin Karikó and Drew Weissman receive Nobel prize

The Nobel Assembly at Karolinska Institutet has awarded the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries that enabled the development of mRNA vaccines against Covid-19. In a statement, the Assembly said: “The discoveries by the two… Read More

#News #Trending News

Doctor prepares vaccine
#Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines #Phase I trial #Rabies #Replicate Bioscience #srRNA

Phase I trial of next-generation srRNA rabies vaccine

Replicate Bioscience has dosed the first participant in a Phase I trial of its RBI-4000 vaccine for the prevention of rabies. The trial, which marks the first time a human has been dosed with Replicate’s srRNA technology, will serve as a benchmark for utility in this… Read More

#News

#Drug development #Elegen #Events #mRNA #mRNA-based vaccines #Webinar

Further insight into breakthroughs in mRNA drug discovery 

DDW recently hosted Where are the breakthroughs in mRNA drug discovery and development? In this webinar, sponsored by Elegen, attendees learnt about the breakthroughs in mRNA drug discovery and development. Watch this on demand now.   Due to technical difficulties, Carsten Rudolph, Managing Director and CEO of Ethris, was unable to… Read More

#Exclusive Content

microRNA
#Drug development #Elegen #Events #mRNA #mRNA-based vaccines #Webinar

Webinar: The breakthroughs in mRNA drug discovery

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” will be free to attend on July 19 at 8AM PDT / 11AM EST / 4PM BST / 5PM CET. Join this free webinar to learn about the opportunities in… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News

#Drug development #Elegen #Events #mRNA #mRNA-based vaccines #Webinar

What does the future hold for mRNA therapeutics? Register now

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” will be free to attend on July 19 at 8AM PDT / 11AM EST / 4PM BST / 5PM CET. Join this free webinar to learn about the opportunities in… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News

Lipid nanoparticle mRNA vaccine
#In Focus Report #mRNA #mRNA-based vaccines #Thermo Fisher Scientific

In depth eReport – mRNA: New uses for this exciting technology

Although the concept of messenger ribonucleic acid (mRNA) as a potential therapeutic technology has been around for decades, it took a global pandemic to give the mRNA platform the necessary shot in the arm and development has proceeded at astonishing speed since. Download this In Focus eReport… Read More

#News

#In Focus Report #mRNA #mRNA-based vaccines #Thermo Fisher Scientific

mRNA: New uses for this exciting technology

Download this In Focus eReport to gain a full understanding of the current market for mRNA vaccines and therapeutics and the areas of greatest commercial potential for the future. The eReport includes: In-depth analysis of regional markets An overview of the likely challenges and opportunities The companies taking the lead… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence